SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-000407
Filing Date
2024-01-02
Accepted
2024-01-02 18:41:51
Documents
2
Period of Report
2024-01-01

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 11274
2 EX-24.1 aktx-ex24_1.htm EX-24.1 14833
  Complete submission text file 0000950170-24-000407.txt   27737
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Issuer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RESTORBIO, INC. 500 BOYLSTON ST., 12TH FLOOR BOSTON MA 02116
Business Address
Grissinger Michael (Reporting) CIK: 0001757601 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36288 | Film No.: 24503893